Filing Flows › Nuo Therapeutics (AURX) › Q2 2026 › vs Q1 2026
Nuo Therapeutics (AURX) Q2 2026 vs Q1 2026 (quarter over quarter)
Nuo Therapeutics's revenue rose $467K (+36%) from $1.3M in Q1 2026 to $1.8M in Q2 2026.
Nuo Therapeutics, Q2 2026: revenue $1.8M (+153% year over year), operating margin -9.4%, net loss $278K, operating cash flow −$236K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $1.3M | $467K | +36% |
| Net loss | $278K | $618K | −$341K | -55% |
| Costs & expenses | $2.0M | $1.9M | $126K | +7% |
| Operating costs | $1.9M | $1.7M | $187K | +11% |
| Interest & other, net | $111K | $172K | −$61K | -35% |
| Cost of revenue | $599K | $452K | $147K | +32% |
| Operating expenses | $1.3M | $1.3M | $40K | +3% |
| Operating cash sources | $304K | $830K | −$526K | -63% |
| Depreciation | $26K | $22K | $4K | +18% |
| Share-based compensation | $41K | $24K | $18K | +76% |
| Cash used in operations | $236K | $784K | −$548K | -70% |
| Net loss absorbed | $278K | $618K | −$341K | -55% |
| Working capital & other | $27K | $212K | −$185K | -87% |
Questions
How much did Nuo Therapeutics's revenue grow quarter over quarter in Q2 2026?
Nuo Therapeutics's revenue rose $467K (+36%) from $1.3M in Q1 2026 to $1.8M in Q2 2026.